Guardian Pharmacy Services, Inc.
No enriched coverage for $GRDN in the last 7 days.
No SEC Form 4 filings for $GRDN in the last 30 days.
Guardian Pharmacy Services, Inc. (GRDN) director Steven D. Cosler was granted 4,028 restricted stock units (RSUs) as part of a compensation package. This award, valued at $0.00 per share, increases his direct holdings to 29,012 Class A common shares. The transaction was reported in a Form 4 filing, indicating a routine equity grant rather than a market purchase or sale.
Guardian Pharmacy Services has released its financial results for the first quarter of 2026, including key financial metrics like revenue and earnings per share. The company also announced a revision to its full-year 2026 financial guidance, reflecting updated expectations based on its performance and current market conditions. This adjustment provides an updated outlook for the remainder of the year.
Raymond James raised its price target on Guardian Pharmacy Services Inc. (NYSE:GRDN) to $40 from $35, maintaining an Outperform rating after strong fourth-quarter 2025 results. The company exceeded revenue and adjusted EBITDA estimates, driven by its successful flu vaccine program. Guardian Pharmacy also raised its 2026 guidance for adjusted EBITDA to $120-124 million, reflecting continued growth and improved operational execution, leading Truist Securities to also increase its price target.
